CRBU logo

Caribou Biosciences (CRBU)

Profile

Full Name

Caribou Biosciences, Inc.

Ticker Symbol

CRBU

Exchange

NASDAQ

Country

United States

IPO

July 23, 2021

Indexes

Not included

Employees

147

Key Details

Price

$0.73(+0.27%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$9.99M(-71.01% YoY)

Annual EPS

-$1.65(-19.57% YoY)

PE ratio

-

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Mar 19, 25 HC Wainwright & Co.
Buy
Jan 7, 25 B of A Securities
Buy
Nov 26, 24 Citigroup
Buy
Nov 15, 24 HC Wainwright & Co.
Buy
Sep 3, 24 HC Wainwright & Co.
Buy
Aug 14, 24 HC Wainwright & Co.
Buy
Aug 7, 24 RBC Capital
Outperform
Jul 17, 24 HC Wainwright & Co.
Buy
Jun 4, 24 HC Wainwright & Co.
Buy
May 16, 24 Truist Securities
Buy

Institutional Ownership

  • What is the ticker symbol for Caribou Biosciences?
  • Does Caribou Biosciences pay dividends?
  • What sector is Caribou Biosciences in?
  • What industry is Caribou Biosciences in?
  • What country is Caribou Biosciences based in?
  • When did Caribou Biosciences go public?
  • Is Caribou Biosciences in the S&P 500?
  • Is Caribou Biosciences in the NASDAQ 100?
  • Is Caribou Biosciences in the Dow Jones?
  • When was Caribou Biosciences's last earnings report?
  • When does Caribou Biosciences report earnings?
  • Should I buy Caribou Biosciences stock now?

What is the ticker symbol for Caribou Biosciences?

The ticker symbol for Caribou Biosciences is NASDAQ:CRBU

Does Caribou Biosciences pay dividends?

No, Caribou Biosciences does not pay dividends

What sector is Caribou Biosciences in?

Caribou Biosciences is in the Healthcare sector

What industry is Caribou Biosciences in?

Caribou Biosciences is in the Biotechnology industry

What country is Caribou Biosciences based in?

Caribou Biosciences is headquartered in United States

When did Caribou Biosciences go public?

Caribou Biosciences's initial public offering (IPO) was on July 23, 2021

Is Caribou Biosciences in the S&P 500?

No, Caribou Biosciences is not included in the S&P 500 index

Is Caribou Biosciences in the NASDAQ 100?

No, Caribou Biosciences is not included in the NASDAQ 100 index

Is Caribou Biosciences in the Dow Jones?

No, Caribou Biosciences is not included in the Dow Jones index

When was Caribou Biosciences's last earnings report?

Caribou Biosciences's most recent earnings report was on Mar 10, 2025

When does Caribou Biosciences report earnings?

The next expected earnings date for Caribou Biosciences is May 7, 2025

Should I buy Caribou Biosciences stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page